1
Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis
Condition(s): Multiple Sclerosis Last Updated: February 18, 2011Completed
15 Clinical Trials for: “3,4-diaminopyridine”, Page 1 of 1
Hide Studies Not Seeking New Volunteers
2
Compassionate Use of 3,4-Diaminopyridine
Condition(s): Lambert Eaton Myasthenic Syndrome (LEMS); Myasthenic Syndromes, Congenital Last Updated: January 8, 2013Available
3
Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
Condition(s): Lambert Eaton Myasthenic Syndrome Last Updated: April 4, 2013Recruiting
4
3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
Condition(s): Lambert-Eaton Myasthenic Syndrome; Congenital Myasthenic Syndrome Last Updated: September 29, 2011Recruiting
5
Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
Condition(s): Lambert-Eaton Myasthenic Syndrome Last Updated: February 22, 2011Available
6
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Condition(s): Lambert-Eaton Myasthenic Syndrome; Eaton-Lambert Myasthenic Syndrome Last Updated: February 14, 2013Recruiting
7
Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism
Condition(s): Botulism Last Updated: June 22, 2012Completed
8
Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
Condition(s): Multiple Sclerosis; Fatigue Last Updated: December 12, 2007Completed
9
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
Condition(s): Lambert-Eaton Myasthenic Syndrome Last Updated: June 23, 2005Completed
10
Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
Condition(s): Lambert Eaton Myasthenic Syndrome (LEMS) Last Updated: December 29, 2011Available
11
DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome
Condition(s): Brugada Syndrome Last Updated: July 1, 2008Not yet recruiting
12
Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Condition(s): Lambert-Eaton Myasthenic Syndrome Last Updated: April 17, 2013Available
13
Treatment of Lambert-Eaton Syndrome With 3,4 DAP
Condition(s): Lambert Eaton Myasthenic Syndrome Last Updated: November 7, 2012Available
14
A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
Condition(s): Lambert Eaton Myasthenic Syndrome Last Updated: April 4, 2013Recruiting
15
Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy
Condition(s): Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Last Updated: June 23, 2005Completed
